A Randomized, Open Label, Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption With DFD-06 Cream Versus Clobetasol Propionate Cream, 0.05% in Subjects With Moderate to Severe Plaque Psoriasis
Phase of Trial: Phase II
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Clobetasol (Primary) ; Corticosteroid
- Indications Plaque psoriasis
- Focus Adverse reactions
- Sponsors Promius Pharma
- 31 Aug 2018 Biomarkers information updated
- 01 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 May 2016 Planned End Date changed from 1 Apr 2016 to 1 Jun 2016.